Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Elisabeth Prevete, Valeria Catalani, Darshan Singh, Kim P. C. Kuypers, Eef L. Theunissen, Honor D. Townshend, Hani Banayoti, Johannes G. Ramaekers, Massimo Pasquini & Ornella Corazza. (2023) A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets. Journal of Psychoactive Drugs 0:0, pages 1-11.
Read now
Read now
Darika Saingam, Darshan Singh, Alan F. Geater, Sawitri Assanangkornchai, Walailuk Jitpiboon & Carl Latkin. (2023) The Health Impact of Long-Term Kratom (Mitragyna Speciosa) Use in Southern Thailand. Substance Use & Misuse 58:10, pages 1212-1225.
Read now
Read now
C. R. LoParco, R. A. Yockey, V. K. Sekhon, S. Olsson, R. Galindo, R. Balasundaram, T. Agwuncha & M. E. Rossheim. (2023) Kratom Retail Availability in Fort Worth, Texas. Journal of Psychoactive Drugs 0:0, pages 1-6.
Read now
Read now
Viktoriya R. Broyan, Jessica K. Brar, Tristen Allgaier, Student & Jeffrey T. Allgaier. (2022) Long-term buprenorphine treatment for kratom use disorder: A case series. Substance Abuse 43:1, pages 763-766.
Read now
Read now
Mike C. Parent, Nathaniel W. Woznicki & Jackie Yang. (2022) Demographic and behavioral factors associated with kratom use among U.S. college students. Journal of American College Health 0:0, pages 1-5.
Read now
Read now
Rana Khudhair Jasim, Zurina Hassan, Darshan Singh, Edward Boyer & Lay-Harn Gam. (2022) Characterization of urinary protein profile in regular kratom (Mitragyna speciosa korth.) users in Malaysia. Journal of Addictive Diseases 40:2, pages 235-246.
Read now
Read now
Gregory Domnic, Suresh Narayanan, Nethia Mohana-Kumaran & Darshan Singh. (2022) Kratom (Mitragyna speciosa Korth.) an overlooked medicinal plant in Malaysia. Journal of Substance Use 27:1, pages 1-6.
Read now
Read now
Mohammad Farris Iman Leong Abdullah, Kok Leng Tan, Suresh Narayanan, Novline Yuvashnee, Nelson Jeng Yeou Chear, Darshan Singh, Oliver Grundmann & Jack E. Henningfield. (2021) Is kratom (Mitragyna speciosa Korth.) use associated with ECG abnormalities? Electrocardiogram comparisons between regular kratom users and controls. Clinical Toxicology 59:5, pages 400-408.
Read now
Read now
Christian Davidson, Dazhe Cao, Taylore King, Stephanie T. Weiss, Sunun Wongvisavakorn, Natthasiri Ratprasert, Satariya Trakulsrichai & Sahaphume Srisuma. (2021) A comparative analysis of kratom exposure cases in Thailand and the United States from 2010-2017. The American Journal of Drug and Alcohol Abuse 47:1, pages 74-83.
Read now
Read now
Adina Bowe & Patrick L. Kerr. (2020) A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management. Journal of Psychoactive Drugs 52:5, pages 447-452.
Read now
Read now
Connor O’Neill-Dee, Henry A. Spiller, Marcel J. Casavant, Sandhya Kistamgari, Thitphalak Chounthirath & Gary A. Smith. (2020) Natural psychoactive substance-related exposures reported to United States poison control centers, 2000–2017. Clinical Toxicology 58:8, pages 813-820.
Read now
Read now
Hannah Wolfer, Roy Gerona & Adam Blumenberg. (2020) Evidence of a potential mechanism for Kratom-related cardiac arrest. Clinical Toxicology 58:8, pages 851-852.
Read now
Read now
Kelsey K. Schmuhl, Spencer M. Gardner, Casey B. Cottrill & Andrea E. Bonny. (2020) Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult. Substance Abuse 41:3, pages 311-314.
Read now
Read now
Darshan Singh, Suresh Narayanan, Shariffah Suraya, Azlin Saref, Oliver Grundmann, Walter C. Prozialeck, Ornella Corazza, Marc T. Swogger, O. Griffin & Vicknasingam Balasingam. (2020) Public Perceptions toward Kratom (Mitragyna Speciosa) Use in Malaysia. Journal of Psychoactive Drugs 52:3, pages 282-288.
Read now
Read now
Jordan R. Covvey, Samantha M. Vogel, Alyssa M. Peckham & Kirk E. Evoy. (2020) Prevalence and characteristics of self-reported kratom use in a representative US general population sample. Journal of Addictive Diseases 38:4, pages 506-513.
Read now
Read now
Azlin Saref, Sharifah Suraya, Darshan Singh, Oliver Grundmann, Suresh Narayanan, Marc T. Swogger, Walter C. Prozialeck, Edward Boyer & Vicknasingam Balasingam. (2020) Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia. Journal of Psychoactive Drugs 52:2, pages 138-144.
Read now
Read now
Charles Veltri & Oliver Grundmann. (2019) Current perspectives on the impact of Kratom use. Substance Abuse and Rehabilitation 10, pages 23-31.
Read now
Read now
Darshan Singh, Suresh Narayanan, Oliver Grundmann, Eshal Bin Dzulkapli & Balasingam Vicknasingam. (2019) Effects of Kratom (Mitragyna Speciosa Korth.) Use in Regular Users. Substance Use & Misuse 54:14, pages 2284-2289.
Read now
Read now
Articles from other publishers (79)
Maximilian Gahr. (2022) Kratom (Mitragyna speciosa): eine psychoaktive Pflanze mit Chancen
und Risiken. Fortschritte der Neurologie · Psychiatrie 91:11, pages 455-465.
Crossref
Crossref
Mary Ann Faucher, Stephanie Morillos, Polly Cordova, Jessica McNeil‐Santiel, Nancy Onisko, Emily H. Adhikari & David B. Nelson. (2023)
Kratom (
Mitragyna speciosa
): A Case Review of Use Before and During Pregnancy
. Journal of Midwifery & Women's Health.
Crossref
Crossref
Rakshit S. Tanna, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel & Mary F. Paine. (2023) Translating Kratom-Drug Interactions: From Bedside to Bench and Back. Drug Metabolism and Disposition 51:8, pages 923-935.
Crossref
Crossref
Katerina Roma, Salman Mohammed, Blake Sieck, Katrina Naik & Shahid Wahid. (2023) Kratom-induced acute liver injury: A case study and the importance of herbal supplement regulation. Journal of Hepatology 79:2, pages 581-584.
Crossref
Crossref
Anees Bahji, M. Eugenia Socías & Paxton Bach. (2023) Cases: Multiorgan failure in a 38-year-old man with recent consumption of kratom, an atypical opioid. Psychiatry Research Case Reports 2:1, pages 100088.
Crossref
Crossref
Rakshit S. Tanna, James T. Nguyen, Deena L. Hadi, Matthew E. Layton, John R. White, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel & Mary F. Paine. (2023) Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom. Clinical Pharmacology & Therapeutics 113:6, pages 1315-1325.
Crossref
Crossref
Donna Papsun, William SchroederIIII, Justin Brower & Barry Logan. (2023) Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy. Current Addiction Reports 10:2, pages 272-281.
Crossref
Crossref
Rana Khudhair Jasim, Darshan Singh & Lay‐Harn Gam. (2022)
Development and validation of ELISA for screening of Kratom (
Mitragyna speciosa
) habitual users using urinary AZ122 biomarker
. Biotechnology and Applied Biochemistry 70:2, pages 707-715.
Crossref
Crossref
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, Abhisheak Sharma, Lance R. McMahon & Christopher R. McCurdy. (2023) Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders. Current Addiction Reports 10:2, pages 304-316.
Crossref
Crossref
Corneliu N. Stanciu, Samantha A. Gnanasegaram, Gerald L. RaderIIIIII, Abhisheak Sharma & Christopher R. McCurdy. (2023) What Is the Kratom Overdose Risk? A Systematic Literature Review. Current Addiction Reports 10:1, pages 9-28.
Crossref
Crossref
Naisarg B Vanani, Stephen G Stevanovic & Nebojsa Stevanovic. (2023) Adverse Drug Interaction Between Kratom and Amitriptyline With Gastrointestinal and Mild Hepatic Effects. Cureus.
Crossref
Crossref
Alyssa M. Falise, Carolin C. Hoeflich, Sara K. Nutley, Catalina Lopez‐Quintero & Catherine W. Striley. (2022)
Polysubstance use profiles among US adults using Kratom (
Mitragyna speciosa
): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)
. The American Journal on Addictions 32:1, pages 76-80.
Crossref
Crossref
Bill J. Gurley, Mitchell R. McGill & Igor Koturbash. (2022) Hepatotoxicity due to herbal dietary supplements: Past, present and the future. Food and Chemical Toxicology 169, pages 113445.
Crossref
Crossref
David Adzrago, Elizabeth O. Obekpa, Tiffany A. Suragh, Evit R. John, Paul G. Yeh, Kathryn R. Gallardo & J. Michael Wilkerson. (2022) Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemic. Drug and Alcohol Dependence 239, pages 109605.
Crossref
Crossref
Hazel D. Brogdon, Mackenzie M. McPhee, Mary F. Paine, Emily J. Cox & Amy G. Burns. (2022) A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone. Journal of Addiction Medicine 16:5, pages 606-609.
Crossref
Crossref
Colin Schwensohn, Johnson NsubugaLaura CronquistGino JoseLaura MastelLaine McCulloughLori SmithMelissa PowellHillary BoothKrisandra AllenAndrew ClassonLaura Gieraltowski. (2022)
A Multiple-Serotype Outbreak of
Salmonella
Infections Linked to Kratom, United States, 2017–2018
. Foodborne Pathogens and Disease 19:9, pages 648-653.
Crossref
Crossref
David A. Gorelick. (2022) Kratom: Substance of Abuse or Therapeutic Plant?. Psychiatric Clinics of North America 45:3, pages 415-430.
Crossref
Crossref
Noah Reich, Grazia Salvo, Dennis Leong, Victoria Wan & Tom Kosatsky. (2022) Kratom exposures managed by the British Columbia poison centre, 2012–2019: a descriptive analysis. CMAJ Open 10:3, pages E755-E761.
Crossref
Crossref
Kathy T. LeSaint, Shan Yin, Abhisheak Sharma, Bonnie A. Avery, Christopher R. McCurdy & Javier C. Waksman. (2022) Acute Renal Insufficiency Associated With Consumption of Hydrocodone- and Morphine-Adulterated Kratom (Mitragyna Speciosa). The Journal of Emergency Medicine 63:1, pages e28-e30.
Crossref
Crossref
George S Behonick, Christina Vu, Larry Czarnecki, Maisie El-Ters & Kevin G Shanks. (2022) Two Single-Drug Fatal Intoxications by Mitragynine. Journal of Analytical Toxicology 46:5, pages e110-e114.
Crossref
Crossref
Chad HartleyIIII, Marilyn Bulloch & Scott R. Penzak. (2022)
Clinical Pharmacology of the Dietary Supplement Kratom (
Mitragyna speciosa
)
. The Journal of Clinical Pharmacology 62:5, pages 577-593.
Crossref
Crossref
Aldo Torres-Ortiz, Said Al Zein & Muhannad Alqudsi. (2022) A Case of Hyperkalemia Induced by Kratom (Mitragyna speciosa). Cureus.
Crossref
Crossref
Vinita Sharma, Linda B. Cottler, Cristina B. Bares & Catalina Lopez-Quintero. (2022) Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health. Journal of Adolescent Health 70:4, pages 677-681.
Crossref
Crossref
Florian Lautenschlager, Manfred Weiss, Sigrun Feuerer & Norbert Wodarz. (2021) Kratom – eine kurze Übersicht für die SchmerzmedizinKratom – a short review for pain medicine. Der Schmerz 36:2, pages 128-134.
Crossref
Crossref
Elisa Lund, Aaron B Low, Jennifer D Allan, Jose A Puentes & David N Flynn. (2022) Anesthetic Challenges Posed by Heavy Kratom Users. Cureus.
Crossref
Crossref
Marc T. Swogger, Kirsten E. Smith, Albert Garcia-Romeu, Oliver Grundmann, Charles A. Veltri, Jack E. Henningfield & Lorna Y. Busch. (2022) Understanding Kratom Use: A Guide for Healthcare Providers. Frontiers in Pharmacology 13.
Crossref
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, Oliver Grundmann, Christopher R. McCurdy, Destiny Schriefer & David H. Epstein. (2022) Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in Pharmacology 13.
Crossref
Crossref
Natasha Tobarran, Carl Wolf, Kirk L. Cumpston & Brandon K. Wills. (2022) Pressure Necrosis Requiring Fasciotomy After Kratom Overdose. Journal of Addiction Medicine 16:2, pages 252-253.
Crossref
Crossref
Islamudin Ahmad, Wisnu Cahyo Prabowo, Muhammad Arifuddin, Jaka Fadraersada, Niken Indriyanti, Herman Herman, Reza Yuridian Purwoko, Firzan Nainu, Anton Rahmadi, Swandari Paramita, Hadi Kuncoro, Nur Mita, Angga Cipta Narsa, Fajar Prasetya, Arsyik Ibrahim, Laode Rijai, Gemini Alam, Abdul Mun’im & Sukanya Dej-adisai. (2022) Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products. Life 12:2, pages 193.
Crossref
Crossref
Yotsapon Thewjitcharoen, Sirinate Krittiyawong, Soontaree Nakasatien & Thep Himathongkam. (2022) Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report. Clinical Medicine Insights: Case Reports 15, pages 117954762211328.
Crossref
Crossref
Catherine W Striley, Carolin C Hoeflich, Andrew T Viegas, Lindsey A Berkowitz, Emily G Matthews, Leyla P Akin, Chidinma Iheanyi-Okeahialam, Urmeen Mansoor & Christopher R McCurdy. (2022)
Health Effects Associated With Kratom (
Mitragyna speciosa
) and Polysubstance Use: A Narrative Review
. Substance Abuse: Research and Treatment 16, pages 117822182210958.
Crossref
Crossref
Inna Larsen, Emily Zhang & Pantea Farahmand. (2022) Current Understanding of the Effects and Potential Clinical Utility of Kratom: A Review. Journal of Psychiatric Practice 28:2, pages 92-97.
Crossref
Crossref
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, Jenny L. Wilkerson, Christopher R. McCurdy & Lance R. McMahon. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status
35
76
.
Shaun L. Greene. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
495
532
.
Sarah Kerrigan & Stephanie Basiliere. (2021) Kratom: A systematic review of toxicological issues. WIREs Forensic Science 4:1.
Crossref
Crossref
Jessicia Schmitt, Kaileigh Bingham & Laura D. Knight. (2021) Kratom-Associated Fatalities in Northern Nevada—What Mitragynine Level Is Fatal?. American Journal of Forensic Medicine & Pathology 42:4, pages 341-349.
Crossref
Crossref
Worrapat Jittasopa & Smith Srisont. (2021) The Causes of Death and Pathological Findings of Kratom Users. American Journal of Forensic Medicine & Pathology 42:4, pages 335-340.
Crossref
Crossref
Mohammad Farris Iman Leong Bin Abdullah & Darshan Singh. (2021) The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Théo Willeman, Hélène Eysseric, Nathalie Allibe, François Chiron, Nathalie Fouilhé Sam-Laï, Michel Mallaret, Françoise Stanke-Labesque & Virginie Scolan. (2021) Intoxication létale au Kratom : investigations toxicologiques d’un cas médicolégal. Toxicologie Analytique et Clinique 33:3, pages S14.
Crossref
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer & Oliver Grundmann. (2021) Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use. Drug and Alcohol Dependence 226, pages 108879.
Crossref
Crossref
Janessa M. Graves, Julia A. Dilley, Lucia Terpak, Ashley Brooks‐Russell, Jennifer M. Whitehill, Tracy A. Klein & Erica Liebelt. (2021) Kratom exposures among older adults reported to U.S. poison centers, 2014–2019. Journal of the American Geriatrics Society 69:8, pages 2176-2184.
Crossref
Crossref
Sanihah Abdul Halim, Jen Hou Low, Yong Chuan Chee & Muhamad Ridzuan Alias. (2021) Seizures among young adults consuming kratom beverages in Malaysia: A case series. Epilepsy & Behavior 121, pages 108057.
Crossref
Crossref
Joseph J. Palamar. (2021) Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample. American Journal of Preventive Medicine 61:2, pages 240-245.
Crossref
Crossref
David Vearrier & Oliver Grundmann. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology 61:S2.
Crossref
Crossref
Alex Hall & Dora Hall. (2021) Kratom Ingestion and Emergency Care: Summary and a Case Report. Journal of Emergency Nursing 47:4, pages 551-556.e1.
Crossref
Crossref
Yuchen Zhou, Steven Ramsey, Davide Provasi, Amal El Daibani, Kevin Appourchaux, Soumen Chakraborty, Abhijeet Kapoor, Tao Che, Susruta Majumdar & Marta Filizola. (2020)
Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception
In Vivo
. Biochemistry 60:18, pages 1420-1429.
Crossref
Crossref
Mahesh Botejue, Gurjot Walia, Omar Shahin, Jyotsna Sharma & Rasiq Zackria. (2021) Kratom-Induced Liver Injury: A Case Series and Clinical Implications. Cureus.
Crossref
Crossref
Shyam H. Kamble, Erin C. Berthold, Tamara I. King, Siva Rama Raju Kanumuri, Raluca Popa, Julius R. Herting, Francisco León, Abhisheak Sharma, Lance R. McMahon, Bonnie A. Avery & Christopher R. McCurdy. (2021) Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats. Journal of Natural Products 84:4, pages 1104-1112.
Crossref
Crossref
Devin J. BurkeSarah G. MahonskiAnne C. Van Cott. (2021) Breakthrough Seizure Associated With Kratom Use in Patients With Epilepsy. Neurology Clinical Practice 11:1, pages 78-84.
Crossref
Crossref
Florian Lautenschlager, Johannes Huebner, Dagmar Steffling, Karl Peter Ittner & Norbert Wodarz. (2021) Kratom: Worauf ist bei einer Intoxikation zu achten?. Der Notarzt 37:01, pages 9-11.
Crossref
Crossref
Rakshit S. Tanna, Dan-Dan Tian, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel & Mary F. Paine. (2021) Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations. Journal of Pharmacology and Experimental Therapeutics 376:1, pages 64-73.
Crossref
Crossref
Jonathan Schimmel, Elise Amioka, Karilynn Rockhill, Colleen M. Haynes, Joshua C. Black, Richard C. Dart & Janetta L. Iwanicki. (2020)
Prevalence and description of kratom (
Mitragyna speciosa
) use in the United States: a cross‐sectional study
. Addiction 116:1, pages 176-181.
Crossref
Crossref
Jawad Ahmad, Joseph A Odin, Paul H Hayashi, Robert J Fontana, Hari Conjeevaram, Bharathi Avula, Ikhlas A Khan, Huiman Barnhart, Raj Vuppalanchi & Victor J Navarro. (2021) Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature. Drug and Alcohol Dependence 218, pages 108426.
Crossref
Crossref
Surash Ramanathan, Francisco León, Nelson J.Y. Chear, Siti R. Yusof, Vikneswaran Murugaiyah, Lance R. McMahon & Christopher R. McCurdy. 2021. Bioactive Natural Products. Bioactive Natural Products
195
225
.
Monique MunAndrew Wong. (2020) Kratom and Phenibut: A Concise Review for Psychiatric Trainees. American Journal of Psychiatry Residents' Journal 16:2, pages 6-8.
Crossref
Crossref
Changho Han, Joza Schmitt & Kristen M. Gilliland. (2019) DARK Classics in Chemical Neuroscience: Kratom. ACS Chemical Neuroscience 11:23, pages 3870-3880.
Crossref
Crossref
Darshan Singh, Paula N. Brown, Eduardo Cinosi, Ornella Corazza, Jack E. Henningfield, Albert Garcia-Romeu, Christopher R. McCurdy, Lance R. McMahon, Walter C. Prozialeck, Kirsten E. Smith, Marc T. Swogger, Charles Veltri, Zach Walsh & Oliver Grundmann. (2020) Current and Future Potential Impact of COVID-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use. Frontiers in Psychiatry 11.
Crossref
Crossref
Darshan Gandhi, Kriti Ahuja, Alexis Quade, Kenneth P Batts & Love Patel. (2020) Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report. World Journal of Hepatology 12:10, pages 863-869.
Crossref
Crossref
Caroline Birer-Williams, Brandon T. Gufford, Eric Chou, Marijanel Alilio, Sidney VanAlstine, Rachael E. Morley, Jeannine S. McCune, Mary F. Paine & Richard D. Boyce. (2020) A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies. Drug Metabolism and Disposition 48:10, pages 1104-1112.
Crossref
Crossref
Alexandra G. Hopkins, Henry A. Spiller, Sandhya Kistamgari, Motao Zhu, Nichole L. Michaels, Alexandra R. Funk & Gary A. Smith. (2020)
Suicide‐related over‐the‐counter
analgesic exposures reported to United States poison control centers, 2000‐2018
. Pharmacoepidemiology and Drug Safety 29:9, pages 1011-1021.
Crossref
Crossref
Andrew Wong & Monique Mun. (2020) A Case of Kratom Overdose in a Pediatric Patient. Case Reports in Psychiatry 2020, pages 1-2.
Crossref
Crossref
Surash Ramanathan & Christopher R. McCurdy. (2020) Kratom (Mitragyna speciosa): worldwide issues. Current Opinion in Psychiatry 33:4, pages 312-318.
Crossref
Crossref
Mohammad Farris Iman Leong Bin Abdullah, Kok Leng Tan, Salbiah Mohd Isa, Nur Sabrina Yusoff, Nelson Jeng Yeou Chear & Darshan Singh. (2020) Lipid profile of regular kratom (Mitragyna speciosa Korth.) users in the community setting. PLOS ONE 15:6, pages e0234639.
Crossref
Crossref
Roberta Gorziza, Joseph Cox, Renata Pereira Limberger & Luis E. Arroyo-Mora. (2020) Extraction of dried oral fluid spots (DOFS) for the identification of drugs of abuse using liquid chromatography tandem mass spectrometry (LC-MS/MS). Forensic Chemistry 19, pages 100254.
Crossref
Crossref
Steven C. Eastlack, Elyse M. Cornett & Alan D. Kaye. (2020) Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review. Pain and Therapy 9:1, pages 55-69.
Crossref
Crossref
Darshan Singh, Nelson Jeng Yeou Chear, Suresh Narayanan, Francisco Leon, Abhisheak Sharma, Christopher R. McCurdy, Bonnie A. Avery & Vicknasingam Balasingam. (2020) Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. Journal of Ethnopharmacology 249, pages 112462.
Crossref
Crossref
Jonathan Schimmel & Richard C. Dart. (2020) Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review. Drugs 80:3, pages 263-283.
Crossref
Crossref
Ashley F. Cowan & Kelly M. Elkins. (2019)
Detection and Identification of Kratom (
Mitragyna speciosa
) and Marijuana (
Cannabis sativa
) by a Real‐Time Polymerase Chain Reaction High‐Resolution Melt Duplex Assay
,
. Journal of Forensic Sciences 65:1, pages 52-60.
Crossref
Crossref
C. James Watson, James D. Whitledge, Alexander F. Barbuto, Katherine L. Boyle & Michael Ganetsky. (2020) Toxicity of agents used for opioid withdrawal: a case-based approach. International Anesthesiology Clinics 58:2, pages 19-27.
Crossref
Crossref
Nicholas Nacca, Rachel F. Schult, Lingyun Li, David C. Spink, Gary Ginsberg, Kristen Navarette & Jeanna Marraffa. (2019) Kratom Adulterated with Phenylethylamine and Associated Intracerebral Hemorrhage: Linking Toxicologists and Public Health Officials to Identify Dangerous Adulterants. Journal of Medical Toxicology 16:1, pages 71-74.
Crossref
Crossref
Deana Goldin, Deborah Salani & Mary Mckay. (2019) Kratom: Implications for Health Care Providers. Journal of Psychosocial Nursing and Mental Health Services 57:12, pages 15-20.
Crossref
Crossref
Elizabeth A.M. Frost. (2019) Kratom: A Cure for Chronic Pain or a Deadly Herb?. Topics in Pain Management 35:5, pages 1-6.
Crossref
Crossref
Stephanie Colucci, Sarah Culbreth, Emad Alsarraf & John Fanikos. (2019) Why Does the Food and Drug Administration Need to Ban Kratom?. Current Emergency and Hospital Medicine Reports 7:4, pages 169-174.
Crossref
Crossref
Emad Alsarraf, Jamie Myers, Sarah Culbreth & John Fanikos. (2019) Kratom from Head to Toe—Case Reviews of Adverse Events and Toxicities. Current Emergency and Hospital Medicine Reports 7:4, pages 141-168.
Crossref
Crossref
C Michael White. (2019) Pharmacologic and clinical assessment of kratom: An update. American Journal of Health-System Pharmacy 76:23, pages 1915-1925.
Crossref
Crossref
Michael Kucharik, Anupam Gupta, Peter Averkiou, George R Luck & Andrew S Ross. (2019) Complicated postoperative course secondary to kratom withdrawal: a case report. Journal of Surgical Case Reports 2019:11.
Crossref
Crossref
William Eggleston, Robert Stoppacher, Kyle Suen, Jeanna M. Marraffa & Lewis S. Nelson. (2019) Drs. Eggleston et al. Reply to Drs. Grundmann et al. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:11, pages 1121-1122.
Crossref
Crossref
John M Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber & Amy Hendricks. (2019) Characteristics of deaths associated with kratom use. Journal of Psychopharmacology 33:9, pages 1102-1123.
Crossref
Crossref
Emily O’Malley OlsenJulie O’DonnellChristine L. MattsonJoshua G. SchierNana Wilson. (2019)
Notes from the Field:
Unintentional Drug Overdose Deaths with Kratom Detected — 27 States, July 2016–December 2017
. MMWR. Morbidity and Mortality Weekly Report 68:14, pages 326-327.
Crossref
Crossref